Column: Not sure what to make of Trump’s drug prices plan? Here’s where to start
Rushing to judgment is misguided. There are no quick fixes here, and while the Trump proposals are viewed as fatally flawed by many experts, they also include some worthy ideas.
Nevada bill would require insulin makers to post profits
The cost of insulin medications has steadily risen over the past decade by nearly 300 percent.
Who wins and loses with the 21st Century Cures Act?
More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies.
Column: Our zeal for antibiotics in agriculture could become an economic nightmare
The superbug is a reminder of the unintended consequences of the modern quest for productivity. Barring a solution, it will take an enormous toll.
The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.
In our news wrap Thursday, embattled ex-Turing Pharmaceuticals CEO Martin Shkreli pleaded the Fifth when called to testify before Congress on drug pricing protocols. Also, 12.7 million Americans signed up for private health insurance under the Affordable Care Act this…
In the 1980s, a law was passed to persuade pharmaceutical companies to develop drugs for small populations, but now that rule is being used to reclaim old "orphaned" drugs in order to raise prices and profits. Gwen Ifill learns more…
Turing Pharmaceuticals sparked outcry when it raised the price of a single pill from $13 to $750. Judy Woodruff discusses the rising costs of prescriptions drugs with Dr. Peter Bach of Memorial Sloan Kettering Cancer Center and Dr. Thomas Stossel…
After outrage from the public and even presidential candidates, Turing Pharmaceuticals has announced it will reduce the price of the drug whose cost had previously increased by more than 5,000 percent practically overnight.
